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ABSTRACT 
Background: Radiofrequency electromagnetic field (RFEMF or simply RF)-based 
electrophysical agents have been employed in therapy-related clinical practice for several 
decades. They are used to reduce pain and inflammation and enhance tissue healing. 
Although these agents have generally become less popular in contemporary therapy 
practice, surveys have shown that some of these modalities are still reasonably widely used. 
Aim: To review the evidence for the use of non-invasive low frequency RFs (30 kHz–30 MHz) 
in therapy-related clinical practice. 
Methods: All peer reviewed therapy-related clinical studies published in English and 
concerning low frequency RF were sought. Identified literature was divided into acute and 
chronic segments based on their clinical area and analysed to assess the volume and scope 
of current evidence. The studies on acute conditions were reviewed in detail for this paper. 
Results: 120 clinical studies were identified, of which 30 related to acute conditions. The 
majority of studies employed Pulsed Shortwave Therapy (PSWT). Twenty two studies out of 
30 were related to conditions of pain and inflammation, seven to tissue healing and one to 
acute pneumothorax. No studies were identified on frequencies other than shortwave. 
Conclusions: Evidence for and against RF-based therapy is available. There is reasonable 
evidence in support of PSWT to alleviate postoperative pain and promote postoperative 
wound healing. Evidence for other acute conditions is sparse and conflicting. A general lack 
of research emphasis in the non-shortwave RF band is evident, with studies on acute 
conditions almost non-existent. Further and wider research in this area is warranted. 
KEY WORDS: Acute conditions, Clinical effects, Electrophysical agents, Non-invasive, 
Radiofrequency. 
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INTRODUCTION 
Electrophysical agents (EPAs) have established themselves over the years as one of the 
pillars of therapy practice. They are used by clinicians all over the world to treat a wide 
variety of conditions. Many of these agents employ some form of electromagnetic fields 
(EMF), in which ‘radiofrequency electromagnetic field’ (RFEMF or simply RF) is a major 
component. Radiofrequency radiations constitute a significant part of the Electromagnetic 
Spectrum. The Institute of Electrical and Electronics Engineers Inc. (IEEE) define RF as EMF 
frequencies between 3 kHz–300 GHz.1,2 This is a broader spectrum compared to the usually 
referred frequency range of 30 kHz–300 MHz.2 This paper aims to review the clinical 
evidence base for RF-based EPAs operating between the frequencies 30 kHz–30 MHz used in 
physical therapy practice. Research employing radiofrequency higher than 30 MHz is 
excluded from this review as it is seldom used in current therapy practice.3 
Though undetectable to the human senses, RF fields are omnipresent and have become an 
unavoidable part of our lives. Their ranges of applications are innumerable in areas such as 
communication, industry and healthcare. In medicine and surgery they play a key role in 
diagnosis, treatment and monitoring of several conditions. The RF literature pertaining to 
these areas in medical science is substantial, and is beyond the scope of this review. 
Similarly, the literature base for the biological effects of RF fields is also extensive and a 
mature scientific discipline with over 60 years of history.4 Hundreds of studies and 
numerous reviews have been published analysing the effects, benefits and hazards of RF on 
the biological systems, either due to intended or due to unintended exposure. Numerous 
studies describing the theoretical underpinning of RF-induced biological effects are also 
available.4-8 Physiological responses to RF-tissue interaction in humans and the mechanisms 
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of actions believed to underpin such responses are well investigated.4,5,7-9 Besides the 
extensive literature on the biological effects of high frequency RF (Microwaves: 300 MHz–
300 GHz), a considerable proportion of studies deal with smaller RF bands that include the 
shortwaves (10–100 MHz) and frequencies below the shortwaves (30 kHz–10 MHz). These 
frequency bands are of particular interest in the therapy arena.2,10-55 
In physical therapy, the use of RF in EPAs has been reported since the early decades of last 
century.56 Mainly three RF modalities were in use, which output contrasting frequencies in 
the RF spectrum. Longwave diathermy, which employs RF fields of around 0.5–1.0 MHz 
became obsolete in the 1950s owing to practical limitations and the severe disturbances it 
caused to communication and broadcasting.57 Shortwave therapy (SWT) (also known as 
shortwave diathermy, or SWD) commonly operating at 27.12 MHz and Microwave therapy 
(also known as microwave diathermy, or MWD) operating at up to 2.45 GHz became more 
established in practice. However, currently microwave therapy is used infrequently in many 
countries.3,58-60 Research pertaining to Microwave therapy and Longwave diathermy are 
excluded from this review. 
Historically, SWT has employed several different frequencies, which are not the same in all 
countries. In 1947, the Federal Communication Commission of the United States 
Government assigned three frequencies at the short end of the RF band (40.68 MHz, 27.12 
MHz and 13.56 MHz) for the medical use of shortwave in an attempt to regulate the use of 
high frequency currents in different disciplines.61 These frequencies used relate to 
international regulation rather than known effectiveness. Of the three frequencies, 27.12 
MHz is the most widely used in current clinical practice.9 
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Shortwave therapy is available in two modes: continuous (CSWT) and pulsed (PSWT). The 
CSWT has been widely used by clinicians since the 1930s, but has now become less popular 
and infrequently used in the western world.3,62 There is in fact an evidence base to support 
the use of CSWT, so the diminishing popularity is partly linked to a ‘fashionable shift’ rather 
than the evidence base per se.9 In contrast, PSWT, which was developed in the 1940s and 
has since become the more popular delivery option, is in use among about 11% of 
outpatient clinics in the UK.3,62,63 In the literature several synonymous terms can also be 
found alongside PSWT, such as pulsed electromagnetic energy (PEME), pulsed 
electromagnetic field (PEMF), pulsed high frequency electromagnetic energy (PHFE) or 
pulsed radiofrequency energy (PRFE) although the majority of such devices employ RF at 
27.12 MHz. This is because some of the device manufacturers used such terms instead of 
the more generic PSWT. Throughout this review the authors will use the term pulsed 
shortwave therapy (PSWT) for consistency. 
In addition to these three modalities, devices operating at significantly lower RF ranges 
(below 1 MHz) have also been reported and have become commercially available. 
Nonetheless, the research in this area is sparse. The authors of this review identified a 
limited number of articles pertaining to this area.46-48,50,64-77 The current literature 
(published in English) indicates that the RF used in therapy-related clinical practice is 
predominantly in the SWT band, and largely limited to PSWT as a delivery mode.3,9,62,78-80 
Although several authors have reviewed the therapeutic effects of SWT as they are applied 
to various specific conditions,56,62,79,81-83 none covers all the therapy-related clinical 
literature in this frequency spectrum. No similar reviews are available on the clinical studies 
that have employed RF below the shortwave frequencies. Furthermore, only a limited 
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number of studies appear in the majority of the reviews identified, owing to their stringent 
inclusion criteria. 
This paper aims to review all therapy-related clinical studies conducted on human patients 
covering the frequency range of 30 kHz–30 MHz and discuss the studies on acute conditions 
in detail. In addition, the authors identified several studies conducted on laboratory animals 
evaluating the effects of RF on experimentally-induced acute conditions. Although these 
studies are beyond the primary remit of this review, it may be of interest to illustrate some 
of the key issues in relation to the clinical studies. Hence, the RF studies performed on 
animals within the referred frequency range will be discussed here prior to the clinical 
literature. 
Experimental studies on animals 
Four animal studies on the effects of SWT on healing of acute wounds were identified; two 
on healing of skeletal muscle injuries14,15 and one each on bone injury51 and skin wound.16 
One study each investigated the resolution of haematomas17 and arthritis20 with the 
application of PSWT. 
In 1951, Hutchison51 conducted two experiments on adult dogs with bilateral tibial grafts 
and adult male rabbits with radial fracture. Conventional CSWT was used in both 
experiments at a ‘mild thermal’ dose (20 minutes twice daily). In both experiments, the 
authors concluded that CSWT ‘significantly delayed’ healing of fractures and bone grafts 
compared to the untreated control group animals. These findings are contrary to the 
findings of the clinical study by Cameron84 (discussed later). Similarly, rabbits with skin cuts 
and guinea pigs with third degree skin burns were subjected to PSWT (38 W MP for 10 
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minutes once daily) by Constable and colleagues.16 Unlike the results from the clinical 
studies, PSWT did not improve wound healing in either of the animal groups. 
Calf muscle injury in rabbits induced by injecting ‘xylocaine’ was treated by PSWT (dose 
parameters not fully reported) for 20 minutes twice daily for either eight or 16 days in the 
study by Brown and Baker.15 While the 8-day treatment failed to influence muscle healing, a 
trend towards enhanced healing was observed with a 16-day treatment programme. In 
another study on the effects of CSWT (five minutes daily for seven days at an intensity 
producing ‘bearable heat’) on induced biceps femoris muscle injury in adult dogs, Bansal 
and colleagues14 demonstrated early maturation of the collagen fibres at the healing site as 
well as regeneration of the injured muscle fibres. It is unclear how the authors were able to 
adjust the dose as ‘bearable heat’ in an animal model. Both the above studies were 
comparable to the clinical studies on postoperative wound healing (discussed later), though 
the results were conflicting. 
Fenn17 reported the effects of PSWT (30 minutes twice daily for 9 days; dose parameters not 
fully reported) on experimental haematomas induced in the ears of 30 male rabbits. Fifteen 
actively treated animals demonstrated a significantly faster resolution of the haematoma 
compared to another group treated with a placebo. Similarly, Nadasdi20 used PSWT (10 
minutes for up to four times; dose parameters not fully reported) in rats with 
experimentally induced arthritis of the tibio-calcaneal joint. Significant inhibition of arthritis 
was obtained with PSWT when compared to the non-treated group. In another study, 
Silverman40 showed that either CSWT or PSWT was no different to a control or a placebo 
condition in treating infected mice. Mice inoculated with pneumococcus bacterial colonies 
were irradiated for 15 minutes twice daily for three days or till the animals died. The 
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treatment failed to improve the outcome. No clinically relevant human studies were 
identified under any of the above three conditions. 
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METHODS 
The authors carried out electronic literature searches as well as hand searches of print 
journals to identify relevant articles. Electronic searches were carried out using the online 
bibliographic databases PubMed, Scopus, ISI Web of Science and CINAHL Plus. Google 
Scholar was also used as an additional source. Articles were also identified by further hand 
searches of the reference lists. References were managed using the EndNote X6 (Thomson 
Reuters) software package. 
Primary searches carried out to identify relevant articles covered publications from all the 
years to date (January 2015). Key search words used were “Radiofrequency”, “RF”, 
“Electromagnet*”, “EMF”, “Shortwave”, “SW” and “Diathermy”, and alternate forms and 
combinations of these keywords. Further filtering was performed using additional search 
words “Biological”, “Clinical”, “Physiological” or “Therapeutic”, and “effects”. All articles 
dealing with the RF frequency range of 30 kHz–30 MHz were retained as a ‘primary pool’. 
This pool contained clinical, non-clinical, animal research, theoretical as well as review 
articles irrespective of the language, study type or methodology. 
From among the clinical studies in this pool, all therapy-related clinical studies published in 
English and conducted solely on human patient(s) employing a non-invasive and non-
ablative methodology were selected for the review. Studies published in languages other 
than English, or conducted in healthy human subjects or in animals were excluded. 
Additionally, studies needed to be conducted on patients in vivo pertaining to any clinical 
area within the realm of therapy and rehabilitation. As identified, some animal studies on RF 
have already been discussed in the introduction to illustrate some key issues. The 
inclusion/exclusion criteria stated above reflect the all-inclusive methodological approach 
10 
 
the authors have followed for the purpose of this review. This approach is dissimilar to that 
of a systematic review and does not exclude studies based on their methodological design 
and/or quality as would be the norm in a systematic review. It is not a novel approach and 
several examples of such reviews can be found in contemporary therapy literature.85-88 
The full-texts of the included studies were obtained. The studies were stratified on the basis 
of the frequency of RF used (shortwave, non-shortwave), the study design (clinical trial, 
cohort study, case series), the duration of clinical condition (acute, chronic) and the clinical 
application category [pain and inflammation, tissue healing, others (all other less reported 
conditions, e.g. – acute pneumothorax)]. For the purpose of this review ‘acute’ is considered 
as conditions not older than 4–6 weeks and ‘chronic’ as conditions older than six weeks. The 
authors understand that it is problematic to divide studies in to distinct categories based on 
the duration of condition or clinical application category as conditions may overlap to a 
varied extent. However, based on examples available from the existing literature89,90 the 
terms ‘acute’ and ‘chronic’ are not explicitly defined and any duration used for 
classifications have been based merely on personal opinion or anecdotal evidence.91 
The studies employing RF devices generating 10–30 MHz were considered as shortwave 
studies, and those employing 30 kHz–10 MHz as non-shortwave studies. The methodological 
quality of the studies were screened using the Cochrane risk of bias assessment tool92 
(where appropriate), and scored based on the checklist proposed by Downs and Black93 for 
randomised and non-randomised studies. This checklist is a valid tool94 containing 27 items 
concerning the quality of reporting, validity, bias and statistical power of the studies 
(maximum score of 32; higher the score better the quality). Over the years, several authors 
have used modified versions of this checklist, mainly by simplifying the ‘item 27’ (originally 
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scored 0–5) that concerns statistical power.95,96 A similar modified version, scoring item 27 
as either ‘zero’ (insufficient power) or ‘one’ (sufficient power) was used in this review. 
Hence, the maximum score that could be obtained by a study was 28. 
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RESULTS 
The flow of studies through the review is given in Figure 1. A ‘primary pool’ of 588 articles 
within the frequency range 30 kHz–30 MHz was generated after the initial screening. Within 
this, 555 articles related to shortwave frequencies and 45 to non-shortwave frequencies. 
Some (12 articles) covered frequency ranges that overlapped these nominal groupings. 
From the primary pool 120 clinical studies met the inclusion criteria for the narrative review. 
Among this, 112 were shortwave studies and eight were non-shortwave studies. Two 
potentially suitable studies employing shortwave were excluded as they had no proper 
abstracts and their full-texts were unavailable through our resources.97,98 Eighty nine studies 
were conducted on conditions relating to pain and inflammation and 23 on conditions 
relating to tissue healing. A further eight studies were classed as ‘others’ and related to a 
mixture of conditions that were relatively less reported (e.g. Acute pneumothorax). 
However, as identified, the authors recognise that it is problematic to classify studies into 
such distinct clinical categories, given that they may overlap to a varied extent. Clearly there 
was potential overlap between studies that considered pain and inflammation and that 
considered tissue healing. For the purpose of this review, the allocation of a particular paper 
to a group was based on the primary outcome(s) as identified by their authors. 
A total of 30 studies investigated acute clinical conditions and 90 investigated chronic 
clinical conditions. Although the overall results of the literature review have been presented 
here, this paper will discuss only the 30 studies on acute conditions. The studies on chronic 
conditions will be discussed in a future separate paper. The full texts were available for all 
the studies discussed here except for two.99,100 
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*Insert Figure 1 here* 
 
*Insert Table 1 here* 
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DISCUSSION OF RESULTS 
The authors of this review identified 30 studies that investigated the effects of RF on acute 
therapy-related clinical conditions. All studies used devices delivering RF energy at the 
shortwave frequency of 27.12 MHz. Overall, 22 studies dealt with conditions pertaining to 
pain and inflammation,101-122 seven to tissue healing84,99,100,123-126 and one study to other 
conditions127 (acute pneumothorax). The studies are considered in detail in the following 
sections. Their key characteristics and Downs and Black scores are briefed in Table 1. 
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STUDIES ON PAIN AND INFLAMMATION 
Studies published on the effects of RF on various acute conditions that give rise to pain and 
inflammation formed the largest group. Nine clinical trials were identified on postoperative 
pain,101,102,106,111,112,119-122 six on ankle injuries,103,105,107,110,113,117 two on fracture pain,116,118 
and one each on hand injuries,109 acute low back pain,108 whiplash injuries115 and pelvic 
trauma in women.114 Besides, there was one case series on RF therapy of soft-tissue injuries 
in professional footballers.104 
Postoperative pain 
In 1968, Kaplan and Weinstock101 achieved significant reduction in postoperative pain, 
oedema and erythema using PSWT on patients who had undergone foot surgery (100 
participants divided in to either active or placebo groups). The participants received PSWT 
for 10–15 minutes twice daily to the operative site as well as to the epigastrium. Later, 
Aronofsky102 achieved comparable results using a similar dose of PSWT on 90 patients (three 
groups of 30 each) who had undergone oral and dental surgical procedures. The active 
group(s) received treatment over the surgical site for two sessions (15 & 10 minutes) pre-
operatively and/or 10 minutes postoperatively. This trial, however, had several 
methodological limitations and lacked objective outcome measures. 
In contrast, PSWT (10 minutes once daily) delivered over the surgical sites of patients who 
had undergone dental surgery failed to improve pain symptoms in the study by Hutchinson 
and colleagues.106 Forty one actively-treated patients were compared to the same number 
of patients who received a placebo. In agreement with Kaplan and Weinstock,101 in the 
study by Santiesteban and Grant111 two sessions of PSWT (30 minutes each) on the day of 
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surgery significantly reduced NSAIDs intake (both the number and strength of doses) and 
the length of hospital stay among 50 patients who underwent foot surgery (two groups of 
25 each). However, it is unclear whether the groups were equal at baseline. In another 
study, no benefit was obtained from ‘non-thermal’ PSWT (15 minutes twice daily for two 
days) in patients who had undergone inguinal herniorrhaphy.112 One may argue though, that 
the intensity of RF applied at a mean power of 0.02 W (Table 1) with a short intervention 
period may only be as good as placebo.27 
There appears to be a chronological gap in this category after which four randomised 
controlled trials (RCTs) have been reported recently on small wearable type RF generators. 
Two studies119,121 on patients who had undergone breast augmentation surgery showed 
beneficial effects of such therapy in terms of reduced postoperative pain and reduced 
consumption of pain medication. In the first study by Heden and Pilla,119 PSWT was 
delivered for 30 minutes 3–6 times daily for the first six days postoperatively; and then 
twice daily until the follow-up visit on day seven. In the second study by Rawe and 
colleagues,121 PSWT was delivered continuously from postoperative day one till day seven. 
Both studies were small and did not employ true control groups. In another small study, 
Rohde and colleagues120 used a similar device and treatment regimen as Heden and Pilla,119 
but in patients who had undergone breast reduction surgery. They demonstrated a three-
fold drop in the pain scores of 12 actively treated patients compared to 12 placebo group 
patients. In this study, a reduction in interleukin 1-β levels of the wound exudate was also 
demonstrated, claiming an RF-induced modulation of the wound healing process. In a 
further study investigating the benefits of wearable PSWT devices,122 57 patients who 
underwent bilateral upper blepharoplasty and received either an active or a placebo PSWT 
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device to their eyes did not report any difference between the two in terms of 
postoperative pain, oedema or ecchymosis. However, there was a statistically significant 
reduction in physician-graded erythema in actively treated eyes compared to the placebo. 
The devices (active for one eye and placebo for the other) were worn for varying durations 
for up to one week postoperatively. However, both active and placebo groups also used 
cold patches where required, but this was not controlled or accounted for in the final 
analysis. 
To conclude, among the studies that investigated the effects of RF on postoperative pain 
conditions, the majority have claimed significant benefits from RF therapy. All studies 
started the RF intervention either pre-operatively or immediately postoperatively. It may be 
noted (Table 1) that the studies that reported no benefit from RF therapy have generally 
employed a lower dose and/or overall duration of intervention. However, because of the 
varied nature of dosage parameters used by the authors any potential range of ideal doses 
could not be identified. The results of the studies in this group need to be considered 
against their overall methodological quality, several of which were problematic, especially 
the earlier studies. The majority did not feature a true control group and failed to 
demonstrate sufficient statistical power or equivalence between the groups at baseline, 
which may serve to weaken their overall impact. Treatment of the epigastric area (over the 
liver) was employed by some earlier studies, as preceding studies performed on healthy 
adults37,128 had reported that it increased peripheral circulation. However, this practice 
became less popular in later years. 
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Acute ankle injuries 
In an RCT by Wilson,103 sixty minutes of PSWT administered for three consecutive days was 
shown to reduce pain and disability among patients (20 active, 20 placebo) who sustained 
acute ankle inversion injuries. The author obtained comparable results in a further study105 
that also employed CSWT and where methods similar to the first study were used. 
Conversely, Pasila and colleagues107 failed to demonstrate any significant difference in pain 
and swelling among 300 patients with recent ankle and foot injuries in a much larger study. 
There were two active groups receiving two types of PSWT, and one placebo group. 
Although the intervention in this study was similar to the study by Wilson,103 the PSWT dose 
was much shorter (20 minutes daily for three days). Similarly, Barker and colleagues110 also 
failed to demonstrate any evidence in support of PSWT for acute ankle injuries (45 minutes 
each for three days) compared to a placebo. The study included a total of 73 participants, 
but experienced high drop-out rates at the follow-up. 
McGill,113 who studied 37 patients (PSWT and placebo groups, no true control group) with 
lateral ligament sprain of the ankle, further reported that PSWT (three 15-minute sessions) 
was not beneficial. The latest study identified in this category was published by Pennington 
and colleagues117 20 years ago. Fifty participants who had suffered grade I–II ankle sprain 
were treated with PSWT or placebo for one session, for a total of 70 minutes given in 
multiple positions (30 minutes medially and 30 minutes laterally to the ankle joint; 10 
minutes to the epigastrium). Significant reduction in ankle oedema was noted in the active 
group compared to the placebo group. 
On the whole, the evidence in this group was equivocal. The RF intervention commenced 
within 36 hours after the injury in all the studies except in two studies107,117 (within 3–4 
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days).107,117 In terms of trial quality, both groups of studies, which were either against or in 
favour of using RF, had several methodological shortcomings including a lack of sufficient 
statistical power, lack of baseline equivalence between the groups, lack of follow-up and 
high drop-out rates. Many studies did not report dosage parameters adequately and for 
others the doses were varied (Table 1). However, where reported it may be noted that 
similar to the studies on postoperative pain, the studies on ankle injuries that reported no 
benefit from RF therapy employed a lower dose and/or overall duration of intervention. 
Fracture pain 
Only two studies were identified in this category. The first study published by Livesley and 
colleagues116 investigated the effects of PSWT (30 minutes daily for 10 consecutive days) in 
the management of fracture of the neck of humerus. Forty eight patients (22 active, 26 
placebo) were treated and followed-up for up to six months. No significant difference was 
found between the groups either for pain or for functional scores at any stage. In the second 
study by Buzzard and colleagues,118 twenty patients presented to a trauma unit with 
unilateral calcaneal fractures were treated either by PSWT (15 minutes twice daily for five 
days) or by ice therapy (‘Cryocuff’ for 20 minutes, six times a day for five days). Daily 
measurements of swelling and ankle ROM showed significant improvement in both groups 
with no significant difference between the groups. Like several previously discussed studies, 
both trials had limited statistical power, lacked a true control group and did not 
demonstrate sufficient equivalence between the groups at baseline. While the dosage 
parameters were inadequately reported in the first study, the second employed a very low 
mean dose of PSWT (Table 1), which arguably was too low to be clinically effective. 
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Other acute conditions with pain 
A case series on the PSWT management of soft tissue injuries in professional footballers was 
published by Wright in 1973.104 A rapid reduction in intra-muscular haematoma was 
reported with repeated daily PSWT for up to a week. In a later clinical trial by Nwuga,108 51 
female patients suffering from acute low back pain were treated with either CSWT (20 
minutes thrice weekly) or spinal manipulation, for up to six weeks. The study showed that 
manipulation was superior to CSWT in terms of improving the spinal and pelvic range of 
movement (ROM). The study, however, did not objectively assess pain or outcomes of 
functional quality of life of the participants. Also, there were no follow-up assessments. The 
generalizability of these findings is limited, as only female subjects were included. 
Similarly, 414 women recovering from pelvic trauma (sustained during childbirth) who were 
studied in four groups (PSWT, ultrasound, placebo-PSWT or placebo-ultrasound) by Grant 
and colleagues114 did not demonstrate any significant difference between the groups at the 
end of treatment. The PSWT treatment was given for 10 minutes daily for three days. 
Although this was a large trial with adequate statistical power, a true control group was 
absent and the outcome measures employed were predominantly subjective in nature. In 
another large trial by Barclay and colleagues109 on 230 patients who had sustained hand 
injuries, 114 active group participants who were treated by PSWT (30 minutes twice daily 
for up to seven days) showed marked reduction in pain, swelling and disability over 116 
control group participants. Similarly, in a well-designed study by Foley-Nolan and 
colleagues,115 20 patients who had sustained acute whiplash injuries treated with PSWT (RF 
generating collar worn for eight hours daily for 12 weeks) reported significant improvement 
in pain compared 20 placebo-treated patients. 
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This group contained a mixture of studies, which have mostly reported favourable results 
for the use of PSWT. As with other groups of studies on pain and inflammation, 
methodological shortcomings (absence of true control group, lack of follow-up, subjectivity 
of outcome measures) and lack of adequate reporting (statistical power, dose parameters) 
were apparent. 
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STUDIES ON TISSUE HEALING 
Out of the seven studies included in this category, five were on healing of postoperative 
wounds,99,100,123-125 and one each on bone healing,84 and healing of lacerated wounds of the 
lower limb.126 All studies used devices delivering RF energy at a frequency of 27.12 MHz. 
Postoperative wound healing 
Five studies examined the effects of SWT on healing of postoperative wounds, of which four 
were clinical trials99,100,123,124 and one cohort study.125 In a double-blinded RCT Bentall and 
Eckstein100 claimed that the rate of bruise resolution in boys who underwent orchidopexy 
operation was significantly better when PSWT (20 minutes locally to the operated site; 10 
minutes to the epigastrium three times a day for four days) was added to the treatment 
programme. Rhodes124 claimed that 247 postoperative patients who had undergone oral 
surgery showed accelerated recovery compared to 254 controls, with daily exposure to 
PSWT (30 minutes locally and 20 minutes over the liver). 
In a further RCT by Goldin and colleagues,123 29 patients who had undergone a skin grafting 
procedure and subsequently received PSWT showed improved healing to the donor site 
compared to 38 patients who received a placebo intervention. One treatment lasting 30 
minutes was given to the donor site at the time of pre-medication and four times daily 
postoperatively, for seven days. Later in a pilot study of 21 cases of blepharoplasty, Nicolle 
and Bentall125 showed enhanced wound healing when treated postoperatively with a 
wearable PSWT device (worn for 24 hours continuously postoperatively). Similarly, 
Arghiropol and colleagues99 suggested that postoperative patients treated locally over the 
operated site by PSWT (15 minutes) and over the liver (30 minutes) presented higher blood 
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plasma levels of fibronectin, which correlated well with a clear improvement of the wound 
healing processes. 
None of the trials discussed in this category employed both placebo and control conditions 
and many failed to establish adequate equivalence between the study groups at baseline. 
All studies started the RF intervention either pre-operatively or immediately 
postoperatively. Similar to the studies on postoperative pain, the dosage parameters where 
reported remained varied, hence any commonalities could not be drawn. 
Other studies on tissue healing  
A study by Cameron84 reported favourable results with PSWT in bone and soft tissue 
injuries. In a mixed design research project containing three separate studies, a total of 646 
surgical and non-surgical orthopaedic patients benefitted from PSWT (20 minutes over the 
liver and 20 minutes over the wound, twice daily for four days). However, despite the 
presence of a large sample, the study lacked a properly randomised methodological design, 
and no standardised outcome measures were used for assessment. In 1991, Muirhead and 
colleagues126 reported an RCT of 129 patients who had sustained lower limb injuries (pre-
tibial lacerations). Sixty six patients in the active group received PSWT (10 minutes three 
times a week) in addition to standard wound dressing. Contrary to the studies discussed 
previously, there was no evidence of accelerated wound healing. This study failed to reach 
adequate statistical power and had a high participant drop-out rate, which was not 
accounted for in the analysis. 
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STUDIES ON OTHER APPLICATIONS 
While the vast majority of RF research in the acute clinical area is centred on applications 
for reducing pain and inflammation, and some others for tissue healing, only one study was 
identified, which investigated the effects of RF on other acute conditions. In a blinded RCT, 
Ma and colleagues127 studied 22 patients with pneumothoraces of less than 30% volume, in 
two groups. One group received a daily dose of CSWT for 25 minutes (at an intensity causing 
‘just perceptible warmth’). The control group participants were kept under observation with 
only bed rest. The time to lung re-expansion was found to be significantly shorter in the 
CSWT group compared to the bed rest group (3–12.5 days and 8–17 days respectively). The 
study, however, is unlikely to have had sufficient statistical power (unreported) with only 11 
subjects per treatment arm. Although this trial was published in 1997 and the results were 
encouraging, no further studies on this condition have been reported since. 
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CONCLUSIONS 
Evidence in favour of and against RF-based therapy for acute clinical conditions is available 
within the referred frequency range. Although the review did not employ a cut-off (Downs 
and Black) score for the methodological quality, the conclusions drawn here are based 
primarily on the results reported by well-designed studies and the overall weightage of the 
available evidence. 
The majority of research is centred on PSWT, with only very few studies conducted on 
CSWT. No studies were identified in the non-shortwave RF range. While the bulk of studies 
that investigated the effects of PSWT on postoperative pain conditions have reported its 
significant benefits, the studies on acute ankle injuries have shown mixed results. As 
identified, there were dose-dependency issues in both these groups. There were limited 
numbers of studies published on the effects of RF-based therapy for other acute conditions 
giving rise to pain. 
Studies have also supported the use of PSWT to promote postoperative wound healing. As 
identified, there was potential overlap between the ‘postoperative pain’ and ‘postoperative 
wound healing’ groups. Hence, on the whole there is reasonable evidence to support the 
use of PSWT for postoperative pain and postoperative wound healing. Since the studies 
employed a wide range of dosage parameters (where reported), it has not been possible to 
identify and recommend an ideal dosage range for the studied conditions based on their 
reported results alone. Evidence for other acute conditions giving rise to pain, concerning 
tissue healing or other less reported conditions is sparse and conflicting. 
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The evidence reported in this review may only be considered against the overall quality of 
the included studies, which was mixed. An apparent lack of robustness and integrity in the 
methodological designs, and infrequent reporting of the RF dosage parameters, outcomes 
and statistical analysis made the assessment of results problematic for many studies. A lack 
of consistency in reporting was particularly evident in the earlier studies. Where doses were 
reported, the rationale for selection was unclear. Additionally, poor baseline equivalence 
between study groups was often evident; and participant drop-outs, which were sometimes 
high were not accounted for in the final analysis (no intention-to-treat analysis) as would be 
the norm in current publications. Owing to the varied nature of methods, outcomes and 
interventions of the included studies, it has not been possible to compare and draw any 
commonalities between them. 
Although RF-based therapy has been in use for almost a century, therapy-related clinical 
research in this area is still scant, with only limited number of studies published on acute 
clinical conditions. The types of such clinical conditions studied for the effects of RF-based 
therapy are even more limited. Clearly there is a need for further research in this area. Even 
though this review considered studies from the frequency of 30 kHz and above, no studies 
on acute conditions employing RF below the shortwave frequency of 27.12 MHz were 
identified. On the whole, a lack of research in the non-shortwave RF band is evident, with 
studies on acute conditions almost non-existent. This warrants research emphasis in this 
area especially since devices delivering non-shortwave RF have long been used in therapy. 
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Figure 1: Flow of articles through the review. 
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Table 1: Key characteristics of the studies on acute conditions. 
Study 
Diagnostic 
category 
Outcomes 
measured 
Study type, 
sample size 
and number 
of groups 
Type of 
RF used 
RF dose parameters 
Number and 
duration of 
sessions 
Did RF 
improve the 
outcomes 
significantly? 
Downs and 
Black score 
(out of 28) 
CSWT 
Power 
(W) 
PSWT 
PP 
(W) 
PD  
(µs) 
PRR 
(pps) 
MP 
(W) 
Kaplan and 
Weinstock 
1968
101
 
Foot surgery 
Pain, oedema and 
erythema 
RCT; 
100 subjects; 
2 groups 
PSWT  
975/
NR 
65 
600/ 
400 
38/ 
NR 
≥7 (over 3 days); 
10–15 
min/session 
Yes 15 
Aronofsky 1971
102
 Dental surgery 
Pain, inflammation 
and ‘healing rate’ 
Non-RCT; 
90 subjects; 
3 groups 
PSWT  975 65 600 38 
≤6 (over 4 days); 
10–15 
min/session 
Yes 9 
Hutchison et al. 
1978
106
 
Dental surgery 
Pain, swelling, 
trismus, analgesic 
intake and 
complications 
RCT; 
82 subjects; 
2 groups 
PSWT  NR 65 500 NR 
5 (over 4 days); 
10 min/session 
No 12 
Santiesteban and 
Grant 1985
111
 
Foot surgery 
Analgesic intake 
and hospital stay 
RCT; 
50 subjects; 
2 groups 
PSWT  120 95 700 8 
2 (over 1 day); 
30 min/session 
Yes 16 
Reed et al. 
1987
112
 
Inguinal 
herniorrhaphy 
surgery 
Pain and analgesic 
intake 
RCT; 
43 subjects; 
2 groups 
PSWT  1 60 320 0.02 
≥4 (over 2 days); 
15 min/session 
No 17 
Heden and Pilla 
2008
119
 
Breast 
augmentation 
surgery 
Pain and analgesic 
intake 
RCT; 
42 subjects; 
3 groups 
PSWT  2 2000 2 0.01 
31 (over 8 days); 
30 min/session 
Yes 22 
Rohde et al. 
2010
120
 
Breast 
reduction 
surgery 
Pain, interleukin 1-
β level and 
analgesic intake 
RCT; 
24 subjects; 
2 groups 
PSWT  2 2000 2 0.01 
12 (over 2 days); 
20 min/session 
Yes 23 
Rawe et al. 
2012
121
 
Breast 
augmentation 
surgery 
Pain and analgesic 
intake 
RCT; 
18 subjects; 
2 groups 
PSWT  
98 x  
10
-4 100 1000 0.001 
7 (over 7 days); 
24 hours/session 
Yes 22 
35 
 
Czyz et al. 2012
122
 
Blepharoplasty 
surgery 
Pain, oedema and 
ecchymosis 
RCT; 
57 subjects; 
2 groups 
PSWT  
9.4 × 
10
-9 10
5
 1000 
0.94 
× 10
-6 
4–10 (over 4–10 
days); 
≈7 hours/session 
No 21 
Wilson 1972
103
 
Ankle soft tissue 
injury 
Pain, swelling and 
disability 
Non-RCT; 
40 subjects; 
2 groups 
PSWT  975 65 600 38 
3 (over 3 days); 
60 min/session 
Yes 16 
Wilson 1974
105
 
Ankle soft tissue 
injury 
Pain, swelling and 
disability 
Non-RCT; 
40 subjects; 
2 groups 
CSWT/
PSWT 
NR 975 65 600 38 
3 (over 3 days); 
30/60 
min/session 
Yes 14 
Pasila et al. 
1978
107
 
Ankle and foot 
soft tissue 
injuries 
Ankle strength, 
range of 
movement, 
swelling and gait 
RCT; 
300 subjects; 
3 groups 
PSWT  NR NR NR 38/40 
3 (over 3 days); 
20 min/session 
No 13 
Barker et al. 
1985
110
 
Ankle soft tissue 
injury 
Pain, swelling, 
range of movement 
and gait 
RCT; 
73 subjects; 
2 groups 
PSWT  NR 65 640 NR 
3 (over 3 days); 
45 min/session 
No 17 
McGill 1988
113
 
Ankle soft tissue 
injury 
Pain and swelling 
RCT; 
37 subjects; 
2 groups 
PSWT  600 400 82 19.6 
3 (over 3 days); 
15 min/session 
No 16 
Pennington et al. 
1993
117
 
Ankle soft tissue 
injury 
Pain and swelling 
RCT; 
50 subjects; 
2 groups 
PSWT  NR NR NR NR 
1 (over 1 day); 
70 min/session 
Yes 18 
Wright 1973
104
 
Lower limb soft 
tissue injuries 
Pain, swelling and 
‘return to function’ 
Case series; 
40 subjects 
PSWT  NR NR NR NR 
≤8 (over ≈7 days); 
NR 
Yes 5 
Nwuga 1982
108
 
Lumbar 
intervertebral 
disc prolapse 
Lumbar range of 
movement 
Non-RCT; 
51 subjects; 
2 groups 
CSWT NR     
≤18 (over ≈6 
weeks); 
20 min/session 
No 14 
Barclay et al. 
1983
109
 
Hand soft tissue 
injuries 
Pain, swelling and 
disability 
RCT; 
230 subjects; 
2 groups 
PSWT  975 65 600 38 
≤14 (over ≈7 
days); 
30 min/session 
Yes 17 
Grant et al. 
1989
114
 
Perineal trauma 
post childbirth 
Pain, oedema, 
bruising, 
haemorrhoids and 
analgesic intake 
RCT; 
414 subjects; 
3 groups 
PSWT  NR 65 100 NR 
3 (over 2 days); 
10 min/session 
No 24 
36 
 
Foley-Nolan et al. 
1992
115
 
Whiplash 
injuries 
Pain, range of 
movement and 
analgesic intake 
RCT; 
40 subjects; 
2 groups 
PSWT  NR 60 450 NR 
84 (over 12 
weeks); 
8 hours/session 
Yes 21 
Livesley et al. 
1992
116
 
Shoulder 
fracture 
Pain, muscle bulk, 
muscle strength, 
range of movement 
and joint function 
RCT; 
48 subjects; 
2 groups 
PSWT  300 NR 35 NR 
10 (over ≈14 
days); 
30 min/session 
No 20 
Buzzard et al. 
2003
118
 
Calcaneal 
fracture 
Swelling and ankle 
range of movement 
Non-RCT; 
20 subjects; 
2 groups 
PSWT  35 200 26 0.18 
10 (over 5 days); 
15 min/session 
Yes, but not 
better than 
ice therapy 
17 
Rhodes 1981
124
 Oral surgery 
Bleeding, healing 
time, return to 
function, pain and 
oedema 
Non-RCT; 
501 subjects; 
2 groups 
PSWT  975 65 
600/ 
400 
38/ 
25.3 
NR adequately; 
40 min/session 
Yes 8 
Goldin et al. 
1981
123
 
Skin graft 
wounds 
Rate of healing and 
degree of pain 
RCT; 
67 subjects; 
2 groups 
PSWT  975 65 400 25.3 
29 (over 7 days); 
30 min/session 
Yes 12 
Nicolle et al. 
1982
125
 
Blepharoplasty 
surgery 
Oedema and 
ecchymosis 
Case series; 
21 subjects 
PSWT  NR 100 1000 NR 
1 (over I day); 
24 hours/session 
Yes 12 
Bentall and 
Eckstein 1975
100
 
Orchidopexy 
surgery 
Oedema and 
healing rate 
RCT; 
100 subjects; 
2 groups 
PSWT  NR 65 500 NR 
12 (over 4 days); 
30 min/session 
Yes NA 
Arghiropol et al. 
1992
99
 
Postoperative 
wound 
Healing rate and 
plasma fibronectin 
concentration 
NA PSWT  
NR/ 
975 
65 
400/ 
600 
NR/ 
38 
NA; 
45 min/session 
Yes NA 
Cameron 1964
84 
Surgical and 
non-surgical 
wounds 
Rate of healing and 
hospital stay 
Non-RCT; 
646 subjects 
(3 studies with 
2 groups each) 
PSWT  NR 65 400 NR 
8 (over 4 days); 
40 min/session 
Yes 5 
Muirhead et al. 
1991
126
 
Pre-tibial 
laceration 
Size of wound and 
healing time 
RCT; 
129 subjects; 
2 groups 
PSWT  NR 400 
20–
46 
NR 
≤18 (over ≈6 
weeks); 
10 min/session 
No 16 
Ma et al. 1997
127
 Pneumothorax 
Time to lung re-
expansion 
RCT; 
22 subjects; 
2 groups 
CSWT NR     
≤13 (over ≈13 
days); 
25 min/session 
Yes 18 
37 
 
 
RCT – Randomised Controlled Trial; RF – Radiofrequency; CSWT – Continuous Shortwave Therapy; PSWT – Pulsed Shortwave Therapy; PP – Peak power; PD – Pulse duration; PRR – Pulse 
repetition rate; MP – Mean power; NR – Not reported; NA – Not available to the authors; W – Watts; µs – Microseconds; pps – Pulses per second; min – Minutes. 
 
